Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open-label Study of the Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19

NCT04459325 is registered in ClinicalTrials.gov with AO GENERIUM as lead sponsor.

NCT NCT04459325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04459325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open-label Study of the Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19
Lead sponsor
AO GENERIUM
Phase
Phase 3
Overall status
Completed
Start date
June 1, 2020
Completion date
July 20, 2020
Enrollment
100 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019, covid-19